Safe Use of CPAP and PEEP During Induction of General Anesthesia

May 4, 2023 updated by: Lennart Edmark, Region Västmanland

Safe Use of CPAP During Preoxygenation and PEEP After Apnoea During Induction of General Anesthesia

The study compares the safety of using pressure controlled ventilation with a positive end-expiratory pressure (PEEP) during induction of general anaesthesia immediately after apnoea to a standard method starting ventilation manually without PEEP immediately after apnoea.

Study Overview

Detailed Description

Using a continuous positive pressure (CPAP) during preoxygenation, followed by pressure controlled ventilation with PEEP after apnoea during induction of general anesthesia, might offer several benefits but safety issues needs more investigation. This study compares the safety of using pressure controlled with PEEP during induction of general anesthesia immediately after apnoea to a standard method starting ventilation manually without PEEP immediately after apnoea.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Västerås, Sweden, 72241
        • Lennart Edmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Normal or overweight patients scheduled for day case surgery in general anesthesia.
  • American Society of Anesthesiologists functional class I-III.
  • Body Mass Index 18.5-30.

Exclusion Criteria:

  • Increased risk of regurgitation of gastric content.
  • Symptomatic asthma, COPD or heart failure.
  • Peripheral oxygen saturation (SpO2) breathing air <94 %
  • Anticipated difficult airway.
  • Beard.
  • Anatomical features making it difficult to keep a tight seal during maskventilation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pressure controlled ventilation with PEEP
In this group, ventilation after apnoea during induction of general anesthesia starts with pressure controlled ventilation with PEEP.
The intervention consists of starting ventilation after apnoea during induction of general anesthesia with pressure controlled ventilation with PEEP instead of manually without PEEP.
Active Comparator: Manual ventilation without PEEP
In this group, ventilation after apnoea during induction of general anesthesia starts with manual ventilation without PEEP.
The intervention consists of starting ventilation after apnoea during induction of general anesthesia manually instead of with pressure controlled ventilation with PEEP.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of breaths until return of CO2.
Time Frame: 2 minutes
When starting ventilation after apnea the number of breaths given until the return of CO2 is at least 1.3 kPa at a respiratory frequency of 10 per minute.
2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 19, 2021

Primary Completion (Actual)

December 20, 2021

Study Completion (Actual)

December 21, 2021

Study Registration Dates

First Submitted

February 13, 2020

First Submitted That Met QC Criteria

February 13, 2020

First Posted (Actual)

February 17, 2020

Study Record Updates

Last Update Posted (Actual)

May 8, 2023

Last Update Submitted That Met QC Criteria

May 4, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Please email request to the study principal investigator.

IPD Sharing Time Frame

Data will be available after publication of study results, approximately 18 months after study completion.

IPD Sharing Access Criteria

Data access requests will be reviewed by a review panel at the Center for Clinical Research, Västerås.

Requestors will be required to sign a data access agreement.

.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Anesthesia

Clinical Trials on Pressure controlled ventilation with PEEP

Subscribe